Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-ketamine versus propofol anesthesia in modified electroconvulsive therapy for major depressive disorder
ChiCTR2000039639Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in major depressive disorder (MDD) (2 arms), sponsored by Tongji Hospital. Primary endpoint: Hamilton Depression Scale (HAMD). Started Nov 2020; status: recruiting.
02
Drugs
esketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on ChiCTR2000039639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000039639.